Re­searchers sug­gest new meth­ods to fi­nance pe­di­atric can­cer R&D — Na­ture pa­per

Re­searchers should re­think how they fi­nance clin­i­cal tri­als for chil­dren’s can­cers in or­der to boost in­vest­ment in pe­di­atric on­col­o­gy R&D, ac­cord­ing to a new pa­per in Na­ture Re­views Drug Dis­cov­ery.

A group of re­searchers in Eu­rope — four from Bel­gium’s Uni­ver­sité Li­bre de Brux­elles and EMA se­nior med­ical of­fi­cer Hans-Georg Eich­ler — made three sug­ges­tions: A pooled fund­ing struc­ture, spe­cial-pur­pose ve­hi­cles and ad­vanced re­im­burse­ment agree­ments.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER